J. Cheung

发表

Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial

F. Martin, S. Sankaralingam, G. Blake, 2003, Osteoporosis International.

Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene

S. Sankaralingam, I. Fogelman, A. Grigoriadis, 2005, Steroids.

Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene.

B. Evans, I. Fogelman, Y. Mak, 2003, The Journal of endocrinology.

Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

W. Fraser, I. Fogelman, M. Frost, 2010, Calcified Tissue International.

Relation between sodium-lithium countertransport and hypertriglyceridemia in type V hyperlipidemia.

A. Wierzbicki, T. Hardman, A. Lant, 2001, American journal of hypertension.

Effects of lipids in patients with familial hypercholesterolaemia on the kinetics of the sodium-lithium countertransporter

M. Lambert-Hammill, A. Lant, S. Patel, 2000, Journal of Human Hypertension.

Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia.

A. Wierzbicki, P. Lumb, M. Crook, 1997, QJM : monthly journal of the Association of Physicians.

Low circulating estradiol and adrenal androgens concentrations in men on glucocorticoids: a potential contributory factor in steroid-induced osteoporosis.

P. Seed, I. Fogelman, G. Hampson, 2002, Metabolism: clinical and experimental.

The effects of dexamethasone and dehydroepiandrosterone (DHEA) on cytokines and receptor expression in a human osteoblastic cell line: potential steroid-sparing role for DHEA.

B. Evans, Y. Mak, G. Hampson, 2006, Cytokine.

Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).

M. Shearer, P. Chowienczyk, A. Wierzbicki, 2011, Bone.

Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women.

S. Ralston, A. Wierzbicki, K. Knapp, 2004, The Journal of clinical endocrinology and metabolism.

The apolipoprotein E2 allele modulates activity and maximal velocity of the sodium-lithium countertransporter.

A. Wierzbicki, P. Lumb, T. Hardman, 2002, American journal of hypertension.